RENALYTIX PLC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch RENALYTIX PLC and buy or sell other stocks, ETFs, and their options commission-free!About RNLXY
Renalytix Plc engages in the manufacturing of medical devices and equipment. It includes the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease.
CEOJames Renwick McCullough, MBA
CEOJames Renwick McCullough, MBA
Employees46
Employees46
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded2018
Founded2018
Employees46
Employees46
RNLXY Key Statistics
Market cap25.50M
Market cap25.50M
Price-Earnings ratio-0.42
Price-Earnings ratio-0.42
Dividend yield—
Dividend yield—
Average volume2.04K
Average volume2.04K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$8.09
52 Week high$8.09
52 Week low$3.13
52 Week low$3.13
Stock Snapshot
As of today, RENALYTIX PLC(RNLXY) shares are valued at $3.85. The company's market cap stands at 25.5M, with a P/E ratio of -0.42.
On 2025-12-17, RENALYTIX PLC(RNLXY) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 2.04K.
Over the past 52 weeks, RENALYTIX PLC(RNLXY) stock has traded between a high of $8.09 and a low of $3.13.
Over the past 52 weeks, RENALYTIX PLC(RNLXY) stock has traded between a high of $8.09 and a low of $3.13.